Multiple Myeloma Clinical Trials Exclude Patients with the Highest-Risk Disease: A Systematic Review of Trial Exclusion Criteria

Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115